Vaccine plus immune cell therapy for kidney cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a combination of a kidney-cancer vaccine and an immune cell treatment to help stop or shrink renal cell carcinoma. It is designed for people who have measurable tumors and are well enough to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have kidney cancer confirmed by biopsy (renal cell carcinoma).
- You are over 18 years old.
- You are generally able to do daily activities (performance status 0–1).
- You have at least one measurable tumor spot that can be tracked by scans.
- You expect to live more than 3 months.
- You can sign informed consent and agree to study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of targeted radiation therapy with a restart of immunotherapy for people whose kidney cancer has grown after prior immunotherapy. It aims to see if radiation can help the immune system fight the cancer again.
This trial tests whether adding a special type of radiation to your current immunotherapy can help shrink kidney cancer tumors that have stopped responding or are stable. The goal is to see if the radiation can boost the immune system's ability to fight cancer elsewhere in the body.
This trial studies whether removing the kidney tumor (cytoreductive nephrectomy) before treatment can improve outcomes for people with metastatic clear-cell kidney cancer. All participants are expected to receive standard immunotherapy (nivolumab plus ipilimumab), and the study focuses on the role of surgery in the “immuno-oncology era.”
This trial tests a new cell therapy (HS-IT101) for people with advanced clear cell renal cell carcinoma, a type of kidney cancer that has spread. The treatment aims to boost the immune system to fight the cancer. Participants must be in good general health and have had no recent cancer treatments.
This trial tests whether starting immunotherapy (a type of medicine that helps your immune system fight cancer) right away, and delaying surgery to remove the kidney tumor, is a safe and effective approach for people with advanced kidney cancer that has spread. It may help you avoid or delay surgery while still controlling the cancer.
This Phase 2 study tests a personalized kidney cancer vaccine made from your own immune cells. It aims to help your immune system recognize and attack clear cell kidney cancer after surgery, potentially lowering the chance of the cancer coming back.
Hear when a new Renal Neoplasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.